参松养心胶囊治疗老年糖尿病心律失常的临床观察

目的观察参松养心胶囊治疗老年糖尿病心律失常的临床疗效。方法将老年糖尿病合并心律失常患者120例随机分为2组,治疗组60例予参松养心胶囊3粒,每日3次口服,对照组60例予心律平100mg,每日3次口服,2组均以8周为1个疗程。观察2组疗效及治疗前后空腹血糖(FPG)、餐后2h血糖(2hPG)、糖化血红蛋白(HbAlc)变化。结果 2组各类心律失常临床疗效相似(P0.05);2组治疗前后FPG、2hPG及HbAlc与本组治疗前及与对照组治疗后比较差异均无统计学意义(P0.05)。结论参松养心胶囊治疗老年糖尿病心律失常疗效确切,不良反应少且轻微。

Clinical observation of Shensong Yangxin Capsule in treating senile diabetic arrhythmia

Objective To explore the clinical efficacy of Shensong Yangxin Capsule on treating senile diabetic arrhythmia.Methods Elderly diabetic patients with arrhythmia were randomly divided into treatment group,which were treated by Shensong Yangxin Capsule,3 pills,thrice a day,and control group,which were treated by propafenone 100 mg,thrice a day.60 cases were in each group.The course of treatment was 8 weeks.The efficacy of 2 groups was observed.And fasting plasma glucose （FPG）,postprandial 2 h plasma glucose （2 hPG） and HbAlc before and after treatment were compared.Results The clinical efficacy of treating arrhythmia was similar between two groups.There was no significant difference between before and after treatment on FPG,2 hPG and HbAlc in two groups （P〉0.05）.Conclusions Shensong Yangxin Capsule has definite effect on senile diabetic arrhythmia.And its adverse reactions were few and mild.